Xiidra Approved on January 20, 2017

Posted in Latest News on January 20, 2017.

Effective January 20, 2017, Rule 64B13-18.002, F.A.C. adds Xiidra (Lifitegrast Ophthalmic Solution) 5% to the formulary and allows Florida Optometrists to prescribe the medication to their patients.



More Latest News

Florida Jurisprudence CE Requirement
February 11, 2019

The Board of Optometry voted to waive the 2-hour Florida Jurisprudence requirement for all out-of-state licensees for the current biennium only. Click Here for more information. Continue reading


Important Notice Regarding Inveltys
February 11, 2019

The Board approved Inveltys (loteprednol etabonate ophthalmic suspension) 1% for addition to Rule 64B13-18.002, F.A.C. Formulary of Topical Ocular Pharmaceutical Agents Continue reading